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SUMMARY 28 
Eukaryotic microalgae and prokaryotic cyanobacteria are the major components of the phytoplankton. 29 
Determining factors that govern growth of these primary producers, and how they interact, is 30 
therefore essential to understanding aquatic ecosystem productivity. Over half of microalgal species 31 
representing marine and freshwater habitats require for growth the corrinoid cofactor B12, which is 32 
synthesised de novo only by certain prokaryotes, including the majority of cyanobacteria. There are 33 
several chemical variants of B12, which are not necessarily functionally interchangeable. Cobalamin, 34 
the form bioavailable to humans, has as its lower axial ligand 5,6-dimethylbenzimidazole (DMB). 35 
Here we show that the abundant marine cyanobacterium Synechococcus synthesises only 36 
pseudocobalamin, in which the lower axial ligand is adenine. Moreover bioinformatic searches of 37 
over 100 sequenced cyanobacterial genomes for B12 biosynthesis genes, including those involved in 38 
nucleotide loop assembly, suggests this is the form synthesised by cyanobacteria more broadly. We 39 
further demonstrate that pseudocobalamin is several orders of magnitude less bioavailable than 40 
cobalamin to several B12-dependent microalgae representing diverse lineages. This indicates that the 41 
two major phytoplankton groups use a different B12 currency. However, in an intriguing twist, some 42 
microalgal species can use pseudocobalamin if DMB is provided, suggesting that they are able to 43 
remodel the cofactor, whereas Synechococcus cannot. This species-specific attribute implicates algal 44 
remodellers as novel and keystone players of the B12 cycle, transforming our perception of the 45 
dynamics and complexity of the flux of this nutrient in aquatic ecosystems. 46 
 47 
  48 
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INTRODUCTION 49 
Eukaryotic microalgae are photosynthetic microbes estimated to be responsible for ~50% of global 50 
carbon fixation [1]. Elucidation of factors that control algal community structure and dynamics is thus 51 
fundamental to understanding the global cycling of carbon. Nutrients such as iron, nitrogen and 52 
phosphorus clearly play an important role [2], but many microalgae also require the vitamins B1 53 
(thiamine), B7 (biotin) or B12 for growth [3]. B12 is required as a cofactor for methionine synthase 54 
(METH) activity, a key enzyme of cellular one-carbon (C1) metabolism important for production of 55 
the universal methyl donor S-adenosylmethionine (SAM), and for folate cycling necessary for DNA 56 
synthesis [4]. Those algae that do not need a supply of B12 cannot synthesise the vitamin, rather they 57 
possess an alternative form of methionine synthase (METE) that can catalyse the same reaction in a 58 
B12-independent fashion [5, 6].  59 
Measurement of B12 levels in the water column have indicated concentrations of ~10 pM in 60 
freshwater ecosystems [7], and are often below the threshold of detection in certain marine habitats, 61 
including large areas of the northeast Pacific margin [8]. The scarcity of this micronutrient is therefore 62 
thought to limit phytoplankton abundance [8], so competition for B12 amongst those organisms that 63 
require/use it is likely. Indeed field enrichment experiments found that whereas N-addition stimulated 64 
all microbial growth, there was a specific growth enhancement of phytoplankton >5 µm (i.e. the larger 65 
eukaryote fraction) with B12 supplementation [9]. However, several recent studies have demonstrated 66 
that heterotrophic bacteria can satisfy microalgal requirements for B12 via mutualistic interactions 67 
[e.g. 5, 10].  68 
Provision from prokaryotes is particularly pertinent since the biosynthetic pathway of this 69 
cofactor is confined to certain archaea and bacteria. B12 is an umbrella term that refers to cobalt-70 
containing corrinoids (ring-contracted tetrapyrroles), which have upper and lower axial ligands to the 71 
cobalt ion (Figure 1A). The nature of these ligands varies, leading to diversity in the structural forms 72 
of B12. Methylcobalamin, where the upper axial ligand is a methyl group, is involved in methyl-73 
transfer reactions, whereas adenosylcobalamin (coenzyme B12) is used for radical based 74 
rearrangements and reductions [11]. The identity of the base found as the lower axial ligand, bound 75 
via a nucleotide loop, may vary too. In cobalamin, the base is 5, 6-dimethylbenzimidazole (DMB). 76 
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Many bacteria, including methanogens and anaerobes such as Clostridium species, synthesise a B12 77 
vitamer known as pseudocobalamin [12, 13], which differs from cobalamin in that DMB is replaced 78 
by adenine. Intrinsic factor, the mammalian B12-binding protein important in uptake from the gut, has 79 
a lower affinity for pseudocobalamin than cobalamin [14]. Pseudocobalamin is therefore considered 80 
not ‘bioavailable’ to humans, and the efficacy of vitamin supplements produced from cyanobacteria 81 
such as Spirulina and Aphanizomenon, which also contain pseudocobalamin, has been questioned [15, 82 
16].  83 
Cyanobacteria are the numerically dominant photosynthetic microbes in the marine 84 
environment [17]. Two cyanobacterial species, Crocosphaera watsonii WH8501 and Synechococcus 85 
sp. WH7803, were reported to release B12 into the media at rates exceeding those estimated for the 86 
heterotrophic bacterium Halomonas, suggesting that cyanobacteria might be the major source of B12 87 
for marine algae [18]. However, indications from the early literature suggest consideration of algal 88 
specificity towards different B12-like factors may be pertinent [19]. Here we investigate corrinoids in 89 
several strains of Synechococcus, an abundant and ubiquitous marine cyanobacterium [17, 20], the 90 
nature of their axial ligands, and their ability to support growth of eukaryotic primary producers. 91 
 92 
RESULTS 93 
Synechococcus species make only pseudocobalamin  94 
The biosynthesis of the corrinoid ring of B12 from the common tetrapyrrole progenitor 95 
uroporphyrinogen III requires at least 20 enzymatic steps, and several routes are known [21]. In a 96 
preliminary investigation, Sañudo-Wilhelmy et al. (2014) [22] searched for the presence of B12-97 
biosynthesis genes in ~40 marine cyanobacteria with sequenced genomes. They found that all but one 98 
species had putative homologues for at least 11 of these genes, and so concluded that they were 99 
capable of making B12. However, they did not investigate the genes involved in synthesis of the lower 100 
axial ligand and so could not conclude whether the cyanobacteria studied produced cobalamin or 101 
pseudocobalamin. To refine the analysis of B12-biosynthesis genes we searched 123 sequenced 102 
cyanobacterial genomes for all 20 genes of the corrinoid pathway. All but six species contained at 103 
least 15/20 of these genes and were predicted to be B12 producers (Dataset S1; Supplemental 104 
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Experimental Procedures). Additionally, we searched for genes involved in DMB biosynthesis, for 105 
which two routes are currently known [23, 24]. The BluB enzyme, first characterised in 106 
Sinorhizobium meliloti (Rhizobia) makes DMB from riboflavin under aerobic conditions [23]. Using 107 
this sequence as a query, no hits were found in 118 cyanobacterial genomes including C. watsonii 108 
WH8501 and Synechococcus sp. WH7803. For 5 species (including 3 from the Fischerella genus), 109 
hits for BluB were obtained: two were annotated as cob(II)yrinic acid a,c-diamide reductase (CobR), 110 
which is an enzyme of an earlier stage of B12 biosynthesis, whereas the others were unknown. In 111 
contrast, BluB homologues were found in 80% of sequenced rhizobia [227/284 genomes, Dataset 112 
S1C] and 60% of Rhodobacterales species [77/128, Dataset S1D) including Mesorhizobium loti, 113 
Sinorhizobium meliloti and Rhizobium leguminosarum and the marine bacterium Dinoroseobacter 114 
shibae, all of which can support algal B12-auxotrophic growth [10, 25]. More recently a second route 115 
for DMB biosynthesis was identified in the obligate anaerobic bacterium Eubacterium limosum [24], 116 
and enzymes encoded by the bzaABCDE operon were shown to direct DMB production via an 117 
oxygen-sensitive reaction from the purine precursor 5-aminoimidazole ribotide (AIR) [24]. We found 118 
that none of the cyanobacterial genomes encoded the full bzaABCDE operon (Dataset S1B). 119 
Moreover, CobT, which is required for DMB activation, is absent from all but two cyanobacterial 120 
genomes. Taken together these searches suggest that the vast majority of cyanobacteria cannot make 121 
DMB, and hence cannot make cobalamin either.  122 
To validate the observations from the bioinformatics analysis, we wanted to assess directly 123 
what corrinoids are synthesized by cyanobacteria, and investigated the B12 content of strains of marine 124 
Synechococcus, since this is an ancient and ecologically abundant lineage [20], with a mean global 125 
abundance of 7.0 ± 0.3 × 10
26
 cells y
−1
 and high biomass-specific CO2 fixation rates [17, 26], and 126 
axenic strains are available. Corrinoids can be extracted from cells as their cyano-derivatives and then 127 
analysed by HPLC-mass spectrometry (LC-MS). First, using purified cyanocobalamin (obtained 128 
commercially) and cyanopseudocobalamin, prepared from Propionibacterium acidi-propionici [12] 129 
we were able to distinguish the two variants of B12 by their different retention times on the LC (Figure 130 
1B) and different mass (Figure S1A and B). Derivatised cell lysate obtained from axenic cultures of 131 
the heterotrophic marine bacterium D. shibae DFL12T contained only cyanocobalamin. We next 132 
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tested five members of the Synechococcus lineage representing different clades and habitats 133 
(highlighted in red in Figure S2): coastal strain CC9311 (sub-cluster (SC) 5.1A, Clade I), oligotroph 134 
WH8102 (SC5.1A, Clade III), WH7803 and WH7805 (SC5.1B, Clades V and VI respectively) which 135 
are widely distributed in various oceanic waters, and the estuarine strain WH5701 (SC5.2). A single 136 
peak was observable in these samples at a retention time consistent with the pseudocobalamin 137 
standard (Figure 1B), and its identity was confirmed by MS (Figure S1D-H). To facilitate subsequent 138 
physiological work, we also tested two model freshwater cyanobacterial species Synechocystis sp. 139 
PCC6803 and Synechococcus elongatus PCC7942, since these species grow quickly and easily in the 140 
laboratory. Again, cell lysates from these strains contained only pseudocobalamin (Figure 1B; Figure 141 
S1I and J). Together these data demonstrate that the cyanobacterial species sampled here make only 142 
pseudocobalamin in axenic laboratory culture conditions. 143 
However, some B12-synthesising bacteria can modify endogenous B12 forms with an 144 
alternative base [27]. For instance although Salmonella enterica cannot make DMB, it can import it 145 
and then make cobalamin instead of pseudocobalamin [27]. To investigate whether Synechococcus 146 
can perform this so-called ‘guided biosynthesis’, we grew strains WH8102 and WH7803 147 
(representing SC5.1A and 5.1B) in the presence of pseudocobalamin and 1 µM DMB, but only 148 
pseudocobalamin was detected (Figure1B; Figure S1K and L). We conclude therefore that 149 
Synechococcus cannot replace the adenine base with DMB to make cobalamin.  150 
 151 
Pseudocobalamin is orders of magnitude less bioavailable to eukaryotic algae 152 
We next tested whether cyanobacterially derived B12 could be utilised by eukaryotic algae. Cell-free 153 
extracts of S. elongatus PCC7942 (pseudocobalamin producer) were unable to rescue growth of the 154 
B12-dependent freshwater alga Lobomonas rostrata, whereas there is clear growth with the addition of 155 
extracts of 3 rhizobial bacteria (Figure S3), which all encode BluB [28]. It is conceivable that the 156 
growth is due to other compounds in the crude lysate, so this initial experiment was extended using 157 
the purified compounds, cyanocobalamin and cyanopseudocobalamin. Equivalent concentrations of 158 
each B12 variant were added to axenic cultures of B12-dependent microalgae from different algal 159 
lineages: marine species Ostreococcus tauri (Chlorophyta, Mamiellophyceae), Amphidinium carterae 160 
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(Alveolata, Dinoflagellate), Pavlova lutheri (Haptophyta, Prymnesiophyceae), Thalassiosira 161 
pseudonana (Heterokontophyta, Coscinodiscophyceae), Aureococcus anophagefferens 162 
(Heterokontophyta, Pelagophyceae), and the freshwater species Euglena gracilis (Excavata, 163 
Euglenozoa) and L. rostrata (Chlorophyta, Volvocales). We also tested a B12-dependent metE mutant 164 
of Chlamydomonas reinhardtii (Chlorophyta, Volvocales) [29]. When pseudocobalamin was supplied 165 
at a concentration of 0.07 or 0.7 nM we observed little or no growth in any of the marine species, nor 166 
with the C. reinhardtii metE mutant or L. rostrata. This is in contrast to cobalamin, which supported 167 
growth of all algal cultures at equivalent concentrations (Figure 2) (Student’s t-test, P<0.05, n=3). For 168 
O. tauri, A. carterae, and T. pseudonana, and to a lesser extent the C. reinhardtii metE mutant, 169 
provision of pseudocobalamin at 7 nM (~10µg/L) supported growth to a similar extent as cobalamin 170 
(Figure 2A, B, D, H), although this amount is significantly higher than found in natural ecosystems 171 
(with reported concentrations ranging from below the detection threshold to 0.03 nM large areas of 172 
the northeast Pacific margin, for instance) [7, 8]. One way to compare the efficacy of the different B12 173 
variants is to carry out dose-response experiments, which enable determination of an EC50 (that is the 174 
concentration required to support half-maximal biomass accumulation) and also provide an indication 175 
of the minimum amount needed to observe any growth, and so we carried these out with the C. 176 
reinhardtii metE
 
mutant. Figure S4 shows that the EC50 was ~0.07 nM for cobalamin, compared to ~7 177 
nM (~100-fold higher) for pseudocobalamin. In addition, it is clear that even the highest concentration 178 
of pseudocobalamin used (40 nM) is not saturating, whereas 0.2 nM cobalamin supports maximum 179 
growth. For E. gracilis some growth was observed even at the lowest pseudocobalamin concentration, 180 
but it was still significantly lower than with cobalamin (Figure 2G). Thus, pseudocobalamin is orders 181 
of magnitude less bioavailable to eukaryotic algae. It is notable to mention that E. gracilis has also 182 
been demonstrated to encode a B12-dependent (type II) ribonucleotide reductase [30], which could 183 
account for the growth response to pseudocobalamin observed in this alga.  184 
 We reasoned that the reduced ability of pseudocobalamin to support growth of algal B12-185 
auxotrophs may be either because the molecule cannot be used as a cofactor, or because it does not 186 
get transported into algal cells. To investigate the latter possibility, we took advantage of the presence 187 
of B12-responsive genes previously identified in the marine diatom Phaeodactylum tricornutum and C. 188 
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reinhardtii [31, 32]. These algae do not need B12 for growth, but will uptake and use it if it is available 189 
[4, 6]. Several genes in these algae are responsive to B12: METE (in P. tricornutum and C. reinhardtii 190 
[6, 31, 32]), CBA1, encoding a novel cobalamin acquisition protein (in P. tricornutum only [31]), and 191 
S-adenosylhomocysteine hydrolase, SAHH (in C. reinhardtii only [32]). Using RT-qPCR we analysed 192 
their expression in cells grown in the presence of 0.7 nM cobalamin or pseudocobalamin. For P. 193 
tricornutum both forms of B12 resulted in down-regulation of METE, but the effect was less 194 
pronounced with pseudocobalamin compared to that with cobalamin (Student’s t-test, P<0.001, n=3) 195 
(Figure 3A). As previously demonstrated, cobalamin supressed CBA1
 
[31] but this gene was 196 
significantly up-regulated by pseudocobalamin (Student’s t-test, P<0.05, n=3) (Figure 3A). In C. 197 
reinhardtii both METE (Student’s t-test, P<0.05, n=3) and SAHH (Student’s t-test, P<0.01, n=3) were 198 
down-regulated relative to the no supplementation control (Figure 3B) with both forms of B12. 199 
Subsequent western blot analysis using polyclonal antibodies against C. reinhardtii METE protein 200 
[32] demonstrated a modest reduction of METE abundance when cells were grown with 201 
pseudocobalamin, although not to the same extent as cobalamin (Figure S5). Nonetheless, the effect 202 
of pseudocobalamin on the expression of these four B12-responsive genes indicates that the molecule 203 
can enter both C. reinhardtii and P. tricornutum cells. 204 
Certain algae are capable of remodelling pseudocobalamin 205 
Some bacteria that do not make B12 can modify imported forms with an alternative base, via 206 
‘corrinoid re-modelling’ [33, 34]. To investigate this possibility in algae, we grew B12-requiring 207 
species in the presence of pseudocobalamin and a range of DMB concentrations. For most, growth 208 
was not restored by DMB supplementation (Figure 4A, B, D-G). However, for P. lutheri, and the C. 209 
reinhardtii metE mutant, addition of DMB alongside pseudocobalamin rescued growth to the same 210 
extent as cobalamin (Figure 4C and H). A dose-response experiment with P. lutheri established an 211 
EC50 value of ~18 pM for cobalamin (Figure 5A). A similar experiment with a fixed concentration 212 
(0.7 nM) of pseudocobalamin but varying the amount of DMB revealed a similar EC50 (~23 pM) 213 
(Figure 5B). Interestingly, an equivalent dose response curve (and EC50 value: ~26 pM) was observed 214 
when cells were grown in medium made using natural filtered seawater rather than artificial sea salts. 215 
Thus the level of DMB in the natural filtered seawater is not sufficient to allow remodelling, 216 
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otherwise the dose-response curve would be shifted to the left. That comparable levels of B12 and 217 
DMB (at a fixed level of pseudocobalamin) are able to rescue B12-dependent growth implies that P. 218 
lutheri is remodelling pseudocobalamin with DMB to generate cobalamin. Dosage experiments with 219 
the C. reinhardtii B12-dependent metE mutant also identified similar EC50 values of ~28 pM and ~70 220 
pM for cobalamin and DMB respectively (Figure 5C and D). In this case the EC50 value for DMB was 221 
slightly higher than cobalamin. We also tested whether C. reinhardtii is capable of de novo lower-222 
loop synthesis, and grew the C. reinhardtii B12-dependent metE mutant with DMB, alongside 223 
(dicyano)cobinamide, a B12 precursor that lacks the DMB ribonucleotide tail. In this case we saw no 224 
restoration of growth (Figure 6A).   225 
Our data indicate that of eight diverse algal species studied, six do not appear to be able to use 226 
exogenous DMB. Nevertheless the observation that growth of the C. reinhardtii B12-dependent metE 227 
mutant (alongside that of P. lutheri) with pseudocobalamin is restored by DMB provision suggests 228 
that these algae are able to chemically modify pseudocobalamin to a form that can support B12-229 
auxotrophic growth. To test more directly whether pseudocobalamin is being remodelled, we grew 230 
samples of C. reinhardtii in the presence of i) cobalamin, ii) pseudocobalamin (1 nM) and iii) 231 
pseudocobalamin (1 nM) +DMB (1 µM) and prepared cell lysate for LC-MS analysis. However, we 232 
could not detect any form of B12 from lysed cells. We infer from this that intracellular B12 levels are 233 
extremely low i.e. the quantity from ~1×10
10
 cells is below the threshold detection of the LC-MS 234 
(which in our system is ~1×10
12
 molecules). Without a clear idea of what order of magnitude more 235 
biomass would be required, and constrained by the limitations of scale we turned to alternative means 236 
of characterising remodelling activity and investigated the effect of DMB + pseudocobalamin on gene 237 
expression in C. reinhardtii. Previously, we had generated several transgenic lines of C. reinhardtii 238 
expressing the B12-responsive element of the METE gene fused to the BLE gene, which confers 239 
resistance to the antibiotic zeocin [32]. This reporter gene construct enables rapid and easy 240 
measurement of B12-responsive gene expression, whereby growth with cobalamin represses 241 
expression of BLE so that cells die in the presence of zeocin (Figure 6B). In contrast pseudocobalamin 242 
alone had little effect, but the inclusion of DMB impaired growth to the same extent as cobalamin, 243 
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demonstrating that C. reinhardtii converts DMB and pseudocobalamin into a form that is able to 244 
repress the METE promoter.  245 
The pathway for pseudocobalamin re-modelling has been investigated previously in the 246 
purple bacterium Rhodobacter sphaeroides, and cobinamide amidohydrolase (CbiZ) and cobinamide-247 
phosphate synthase (CbiB) have been implicated in this process [34]. We could not identify cbiZ, or 248 
cbiB in any of the algal genomes we analysed. We therefore searched for proteins shown to be 249 
involved in lower-loop assembly and activation [34] in S. enterica (CobT, CobS and CobC) [27], 250 
where mutants of CobT are unable to incorporate exogenous DMB (Figure 6C). We identified genes 251 
encoding all three of these proteins in C. reinhardtii, which exhibits the remodelling phenotype (Table 252 
S1; Figure 5). In contrast, BLASTP searches of the genomes of O. tauri and T. pseudonana, species 253 
that do not appear to remodel, were negative for CobT and CobS. Although a hit for CobC was 254 
identified in T. pseudonana, it should be noted that CobC catalyzes the dephosphorylation of the 255 
AdoCbi-GDP precursor and therefore BLAST searches may retrieve genes encoding unrelated 256 
kinases. Interestingly, we identified hits for CobT and CobC but not CobS in A. anophagefferens, 257 
which can use pseudocobalamin but only with very high levels of DMB (10 µM) (Figure 4E). A 258 
transcriptome sequence for P. lutheri is available via the Marine Microbial Eukaryote Transcriptome 259 
Sequencing Project (MMETSP), a transcriptome database of 396 unique strains representing 260 
ecologically significant and taxonomically diverse marine microbial eukaryotes [35]. This alga, which 261 
can use pseudocobalamin alongside DMB, also expresses COBT, COBS and COBC (Dataset S2A). 262 
Thus the presence of these novel proteins correlates with the ability to remodel pseudocobalamin, 263 
implicating them in B12 metabolism. We also identified another 46 candidate remodellers in the 264 
MMETSP (Dataset S2A), including several that encoded METE, and so are like C. reinhardtii in 265 
being independent of a source of B12 for growth. In total the potential remodellers represented ~11% 266 
of unique strains, and included representatives of the higher class levels Alveolata, Stramenopila, 267 
Hacrobia, and Viridiplantae (Dataset S2B). Incidentally, none of the 268 
sequenced Synechococcus genomes encode CobT (Dataset S1), which might explain 269 
why Synechococcus strains cannot remodel pseudocobalamin to cobalamin in the presence of DMB 270 
(Figure 1B).   271 
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 272 
DISCUSSION 273 
Eukaryotic microalgae and cyanobacteria are the major components of the phytoplankton in marine 274 
and freshwater systems. Since they both inhabit the photic zone, they will compete for resources 275 
including light and limiting nutrients such as nitrogen and Fe. We have demonstrated that, in contrast 276 
to heterotrophic bacteria such as D. shibae (and certain rhizobial bacteria
 
[28]) that make cobalamin, 277 
members of the ubiquitous marine Synechococcus genus synthesise only pseudocobalamin, in which 278 
the lower base is adenine instead of DMB (Figure 1). Moreover, a survey of diverse cyanobacterial 279 
genomes, encompassing marine and freshwater species, showed the vast majority lack BluB and the 280 
bzaABCDE operon (Dataset S1) [23, 24]. This strongly suggests that pseudocobalamin is the major 281 
form of B12 synthesised by most if not all cyanobacteria.  282 
We found that pseudocobalamin is considerably less bioavailable than cobalamin to several 283 
B12-dependent algae (Figure 2). This reduced bioavailability suggests these organisms are 284 
compromised in their ability to acquire or use pseudocobalamin as a cofactor. Human intrinsic factor, 285 
part of the B12 uptake system in the gut, exhibits a 500-fold-lower binding affinity for 286 
pseudocobalamin [14], thus reducing the bioavailability of the compound to humans. In algae, 287 
currently only one protein has been implicated in B12 uptake [31] (CBA1), although the precise 288 
molecular mechanism and role of CBA1 in B12 binding are not fully understood. Nevertheless, the 289 
ability of pseudocobalamin to affect the expression of algal B12-responsive genes (Figure 3) and 290 
protein levels (Figure S5) suggests this compound can enter algal cells, albeit that it has the opposite 291 
effect on CBA1 to cobalamin, suggesting that the cells are experiencing cobalamin-deficiency. 292 
Transport of pseudocobalamin into the cell is also indicated by our observed remodelling of 293 
pseudocobalamin in C. reinhardtii and P. lutheri following DMB addition (Figure 4 and 5). The 294 
identification of genes encoding enzymes of lower ligand activation (COBT) and nucleotide-loop 295 
assembly (COBS) [27] in these algae (Table S1) provides a likely mechanism for corrinoid 296 
remodelling. We found no evidence of secretory peptide signals in C. reinhardtii COBT or COBS 297 
using the green algal subcellular localization tool ‘PredAlgo’ [36], indicating that remodelling 298 
presumably takes place within the cell, and providing further support for the ability of 299 
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pseudocobalamin to be taken up. Whether these genes have been acquired through lateral gene 300 
transfer from a bacterial source, which is thought to be the case for E. coli [37], remains unknown. 301 
However, of the non-algal sequences retrieved via a BLAST search of the NCBI non-redundant 302 
database with the C. reinhardtii COBT/COBS top hits were derived from the amphipod associated 303 
protist species Aphanomyces astaci (4e
-57
) and Sphaeroforma arctica (7e
-77
), respectively. A broader 304 
phylogenetic analysis of COB genes will be integral to further understanding of what, at a first glance, 305 
appears to be an intriguing evolutionary history. Since algae rely on B12 for METH [5], the function of 306 
pseudocobalamin as a cofactor for this enzyme is also an important question. Structural data available 307 
for the B12-binding pocket and the active site of METH [38, 39] implicates several amino acids in B12 308 
binding, with the DMB ‘tail’ buried within a cleft of the active site [40]. Since pseudocobalamin 309 
contains an alternative lower base to B12 it seems plausible that algal METH proteins may have 310 
reduced binding affinity for pseudocobalamin.  311 
The combination of DMB with pseudocobalamin improves the bioavailability to certain 312 
algae. We infer from this that these remodelling algae are able to generate cobalamin from 313 
pseudocobalamin + DMB, although we were unable to measure detectable levels of any form of B12 in 314 
C. reinhardtii cells grown with pseudocobalamin plus DMB. It is possible therefore that another form 315 
of the vitamin is being generated, though we deem this unlikely. In any case, our results highlight the 316 
importance of considering environmental concentrations of DMB. A bioassay to measure free DMB 317 
concentrations was recently reported [41]. Analysis of samples derived from host-associated 318 
(termite/rumen) and natural environmental samples (Eucalyptus grove soil/creek water) determined 319 
concentrations in the picomolar and sub-picomolar range. Our observation that P. lutheri (whose 320 
growth can be supported by pseudocobalamin + DMB) could not grow in natural seawater from the 321 
English Channel supplemented with pseudocobalamin (Figure 5B), suggests DMB levels were not 322 
sufficient in these coastal waters to support remodelling. Nevertheless, further work is required to 323 
quantify DMB in marine (and freshwater) environments more broadly. In a similar vein, whilst a 324 
recent field study by Heal et al (2015) quantified the relative abundance of four upper axial variants of 325 
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B12 (CN, Me, Ado, and OH) in estuarine waters of the Puget Sound, levels of lower axial ligand 326 
variants are unknown [42].  327 
Members of all three domains of life require B12, yet its biosynthesis is limited to a subset of 328 
prokaryotes. As such, the flux of B12 between microbes is integral to the growth of auxotrophic 329 
species. Our results imply heterotrophic bacteria are likely to be a more important source of B12 for 330 
eukaryotic algae than cyanobacteria. An increasing body of evidence, provided by this study and 331 
others [33, 34, 43, 44], suggests the relationship between requirers and providers has become blurred 332 
by the existence of scavengers, and re-modellers. That different B12 forms are not functionally 333 
equivalent between organisms means that biochemical transformations between vitamer classes are 334 
essential for this micronutrient to reach different members of the community. This complicates our 335 
current view of B12 cycling in aquatic environments (Figure 7). Whether cyanobacteria synthesise a 336 
currency of B12 that is inaccessible to competing eukaryotic microbes as a strategy to exclude 337 
competitors remains unknown. Nevertheless, the observation that certain algae possess a counter-338 
mechanism, to convert pseudocobalamin to a bioavailable form, suggests the selective pressure to 339 
devise and refine strategies of B12 acquisition/utilization in order to elevate accessibility to this 340 
limiting micronutrient is strong. In any case, the importance of B12 and its derivatives in structuring 341 
microbial communities in aquatic ecosystems may have been previously underestimated.  342 
 343 
EXPERIMENTAL PROCEDURES 344 
Bioinformatics approaches 345 
A full description of sequence similarity search parameters is provided in the Supplemental 346 
Experimental Procedures. 347 
 348 
Chemicals 349 
Upper axial cyano forms of cobalamin/pseudocobalamin were used for all B12-amendment 350 
experiments. Cyanocobalamin was purchased from Sigma-Aldrich UK. Cyanopseudocobalamin was 351 
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prepared by guided biosynthesis from a culture of Propionibacterium acidi-propionici DSM 20273 as 352 
described previously, and confirmed by UV-Vis, CD, mass, and NMR spectroscopic analysis [12]. 353 
 354 
Strains and growth conditions 355 
Details of microbial strains and culture conditions are provided in the Supplemental Experimental 356 
Procedures and Table S2.  357 
Molecular Methods 358 
RNA extraction and reverse transcription quantitative real-time PCR (RT-qPCR) 359 
Total RNA was extracted [6] and treated with the Ambion Turbo DNase-Free Kit to remove genomic 360 
DNA. RNA was reverse transcribed into cDNA with SuperScript II (Invitrogen). Details of RT-qPCR 361 
are given in the Supplemental Experimental Procedures and Table S3. 362 
Western blotting 363 
Total protein was extracted, and Western blot experiments performed as described in [32]. 364 
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Figure Legends: 505 
 506 
Figure 1 Synechococcus strains synthesise pseudocobalamin rather than cobalamin. A. Structural 507 
Variants of B12. B. HPLC-MS extracted ion chromatograms for m/z 1355.5 cyanocobalamin and m/z 508 
1344.5 cyanopseudocobalamin (see also Figure S1). The lower tracks displays the chromatograms for 509 
cell-free extracts derived from cultures of cyanobacterial species from (Figure S2). Experiments were 510 
carried out in triplicate and one replicate representative of each strain is shown.  511 
 512 
Figure 2 Pseudocobalamin poorly supports growth of B12-dependent eukaryotic algae. Growth 513 
yield (OD730) of algae in liquid medium supplemented with or without cyanocobalamin or 514 
cyanopseudocobalamin (at 0.07, 0.7 or 7 nM) in batch culture after at least two transfers (until the 515 
cells had died in the -B12 treatment). A. O. tauri, B. A. carterae, C. P. lutheri, D. T. pseudonana, E. A. 516 
anophagefferens, F. L. rostrata G. E. gracilis, H. C. reinhardtii B12-dependent metE mutant [27]. Cbl 517 
= cyanocobalamin; PsCbl = cyanopseudocobalamin. *P ≤ 0.05, **P ≤ 0.01, ***P≤0.001 compared 518 
with the equivalent concentration of Cbl (two-tailed Student’s t-test) (mean ± SEM, n=3). See also 519 
Figure S3 and S4.  520 
 521 
Figure 3 Pseudocobalamin affects expression of B12-responsive genes in P. tricornutum and C. 522 
reinhardtii. RT-qPCR analysis of A. METE and CBA1 expression in P. tricornutum and B. METE and 523 
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SAHH expression in C. reinhardtii, without B12 or with 0.7 nM Cbl/PsCbl. Expression was 524 
normalized using three house-keeping genes: Histone H4; 30S, Ribosomal protein S1, RPS; and 525 
TATA box-binding protein, TBP for P. tricornutum and Receptor of activated protein kinase C 1, 526 
RACK 1; Actin, ACT; Ubiquitin, UBQ for C. reinhardtii. *P ≤ 0.05, **P ≤ 0.01, ***P≤0.001 527 
compared to the –B12 treatment (two-tailed Student’s t-test) (mean ± SEM, n=3). See also Figure S5. 528 
 529 
Figure 4 Provision of lower ligand substrate DMB together with pseudocobalamin can support 530 
growth of certain B12-dependent algae. Species were grown in liquid medium (Table S2) without or 531 
with 0.7 nM cobalamin (open bars) or 0.7 nM pseudocobalamin (shaded bars) in the presence of 532 
different DMB concentrations in batch culture over several transfers, or until the cells had died in the 533 
-B12 treatment. A. O. tauri (OTH95), B. A. carteri, C. P. lutheri, D. T. pseudonana, E. A. 534 
anophagefferens , F. L. rostrata G. E. gracilis, H. C. reinhardtii, B12-dependent evolved (metE
-
) 535 
mutant line [29]. Optical density (OD730) was used to quantify growth (mean ± SEM, n=3). 536 
 537 
Figure 5 Certain algae can remodel the lower axial ligand of pseudocobalamin with exogenously 538 
supplied DMB. Relative growth yield of A. P. lutheri cells supplemented with different 539 
concentrations of cobalamin after 19 days (values of OD730
 
were
 
normalised
 
as a proportion of growth 540 
at 1000 pM B12) or B. P. lutheri cells supplemented with different concentrations of DMB in the 541 
presence of 0.7 nM pseudocobalamin (after 19 days) in artificial seawater or natural filtered seawater 542 
(values of OD730
 
normalised
 
to growth at 1000 pM DMB). Equivalent experiments with C. reinhardtii, 543 
evolved B12-dependent metE mutant [29] are displayed in panels C & D after 96 hours growth (mean 544 
± SEM, n=3). 545 
 546 
Figure 6A. Relative growth yield (OD730) of C. reinhardtii B12-dependent mutant grown with DMB 547 
alongside (dicyano)cobinamide, a B12 precursor that lacks the DMB ribonucleotide tail. Cells were 548 
grown in liquid medium (Table S2) with 0.7 nM cobalamin (open bars) 0.7 nM pseudocobalamin 549 
(grey bars), or 0.7 nM dicyano)cobinamide (black bars) in the presence of different DMB 550 
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concentrations. B. Relative growth yield (OD730) of C. reinhardtii reporter line containing a zeocin 551 
resistance gene controlled by the METE promoter [32] after 13 days in the presence (white bar) or 552 
absence (black bar) of DMB (1 µM) and 20 µg/mL zeocin without or with 0.7 nM cobalamin or 553 
pseudocobalamin. Values of OD730
 
were
 
normalised
 
as a proportion of growth with no B12 (mean ± 554 
SEM, n=3). C. The pathway for the activation of DMB and nucleotide loop assembly in S. enterica 555 
(adapted from [23]. CobT catalyses the attachment of a phosphoribose moiety derived from nicotinate 556 
mononucleotide to form α-ribazole phosphate. CobS and CobC catalyse the attachment of the 557 
activated base to the cobamide precursor (GDP-cobinamide).  558 
 559 
Figure 7 Complex B12 cycling in a ‘hypothetical’ marine microbial community. Cobalamin 560 
produced by heterotrophic bacteria such as Dinoroseobacter sp. is directly usable by algal B12 561 
auxotrophs representing major marine taxa, whereas cyanobacterially-derived pseudocobalamin is 562 
not. However, those algae like P. lutheri capable of remodelling can access this essential cofactor if 563 
DMB is also present. 564 
